Page last updated: 2024-08-26

fructose 2,6-diphosphate and Kahler Disease

fructose 2,6-diphosphate has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, Z; Liu, X; Lv, N; Yan, H; Zhang, E; Zhao, Y	1

Other Studies

1 other study(ies) available for fructose 2,6-diphosphate and Kahler Disease

Article	Year
The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3. Biochemical and biophysical research communications, 2019, 07-23, Volume: 515, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Enzyme Inhibitors; Fructosediphosphates; Glucose; Humans; Hypoglycemic Agents; Metformin; Multiple Myeloma; Phosphofructokinase-2; Pyridines; Quinolines; RNA, Messenger; Signal Transduction	2019

Article

Year

The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3.

Biochemical and biophysical research communications, 2019, 07-23, Volume: 515, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Enzyme Inhibitors; Fructosediphosphates; Glucose; Humans; Hypoglycemic Agents; Metformin; Multiple Myeloma; Phosphofructokinase-2; Pyridines; Quinolines; RNA, Messenger; Signal Transduction

2019